Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer

British Journal of Radiology

Volumn 85, Issue 1016, 2012, Pages

  Choi, S Y ^a   Chang, Yun Woo ^a   Park, H J ^a   Kim, H J ^a   Hong, S S ^a   Seo, D Y ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Korea Polytechnic University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLOOD VESSEL PARAMETERS; BREAST CANCER; CANCER PROGNOSIS; CANCER SIZE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULAR DENSITY; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; KI-67 ANTIGEN; MICROVESSELS; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84864831386     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/79381464     Document Type: Article

References (29)

1. Kim SH, Cha ES, Kin HS, Kang BJ, Choi JJ, Jung JH, et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 2009;30:615-20.
2. Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, et al. Diffusion-weighted Imaging of malignant breast tumors. J Comput Assist Tomogr 2005;29:644-9.
3. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26:1042-6. (Pubitemid 36076728)
4. Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008;26:222-6. (Pubitemid 351754726)
5. Guo Y, Cai YQ, Cai ZL, Gau YG, An NY, Ma L, et al. Differentiation of clinical benign and malignant lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172-8. (Pubitemid 34810055)
6. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8:390-6.
7. Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMarini WB, Eby PR, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010;194:1664-73.
8. Jeh SK, Kim SH, Kim HS, Kang BJ, Jeong SH, Yim HW, et al. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 2011;33:102-9.
9. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17:2646-55.
10. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006;24:319-24. (Pubitemid 44188557)
11. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15:693-704. (Pubitemid 34606504)
12. Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast enhanced and diffusion-weighted MR images. J Magnet Reson Imaging 2008;28:1157-65.
13. Kuroki Y, Nasu K, Kuroki S, Murakami K, Hayashi T, Sekguchi R, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004;3:79-85.
14. Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7:23-9.
15. Makkat S, Luypaert R, Stadnik T, Bourgain C, Sourbron S, Dujardin M, et al. Deconvolution-based dynamic contrast enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings - preliminary results. Radiology 2008;249:471-82.
16. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 2007;109:1721-8. (Pubitemid 46668532)
17. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer; experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
18. Szabo BK, Aspelin P, Wiberg MK, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-35. (Pubitemid 37407473)
19. Pererira FPA, Martins G, Figueiredo E, Domingues MNA, Domingues RC, da Fonseca LMB, et al. Assessment of breast lesions with diffusion-weighted MRI: Comparing the use of different b values. AJR Am J Roentgenol 2009;193:1030-5.
20. Tsushima Y, Takahashi-Taketomi A, Endo K. Magnetic resonance (MR) differential diagnosis of breast tumor using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 2009;30:249-55.
21. Costantini M, Belli P, Rinaldi P, Bufi E, Giardina G, Franceschini G, et al. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumor aggressiveness. Clin Radiol 2010;65:1005-12.
22. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-49. (Pubitemid 26282258)
23. Razek AA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 2010;23:619-23.
24. Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997;47:28-51. (Pubitemid 27050848)
25. Ludovini V, Sidoni A, Pistola L, Bellezza G, De Angelis V, Gori S, et al. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res Treat 2003;81:159-68. (Pubitemid 37211133)
26. Black R, Prescott R, Bers K, Hawkins A, Stewart H, Forrest P. Tumor cellularity, estrogen receptors and prognosis in breast cancer. Clin Oncol 1983;9:311-18. (Pubitemid 14210887)
27. Ding SL, Sheu LF, Yu JC, Yang TL, Chen B, Leu FJ, et al. Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma. J Biomed Sci 2004;11:911-19. (Pubitemid 39664245)
28. Bogner W, Gruber S, Pinker K, Grabner G, Stadlbauer A, Weber M, et al. Diffusion-weighted MR for differentiation breast lesions at 3.0T: how does selection of diffusion protocols affect diagnosis? Radiology 2009;253:341-51.
29. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 2009;193:840-9.